The Blake Leeper Case - CAS Panel Rejects Double Amputee’s Appeal To Compete At The Olympics

The Blake Leeper Case - CAS Panel Rejects Double Amputee’s Appeal To Compete At The Olympics
Wednesday, 03 March 2021 By Simon Watts-Morgan

A recent award handed down by the Court of Arbitration for Sport[1] has found in favour of World Athletics in its dispute with the US Paralympian 400m sprinter, Blake Leeper, concerning the athlete’s eligibility to run against able-bodied athletes in World Athletics Series competitions as well as the upcoming Tokyo Olympics. 

This article reviews the case, examining:

  • Who is Blake Leeper?
  • The Nature of the Dispute
  • The CAS Verdict
    • Burden of Proof
    • Overall Competitive Advantage
  • Differences to the Pistorius Award
  • Moving Forward

Continue reading this article...

Register with your email and password
Already a member? Sign in

Get access to all of the expert analysis and commentary at LawInSport including articles, webinars, conference videos and podcast transcripts.  Find out more here.

Related Articles

Written by

Simon Watts-Morgan

Simon Watts-Morgan

Simon is a Trainee Solicitor at Squire Patton Boggs based in London.

Comments (1)

  • Josep F. Vandellos Alamilla

    • 21 March 2021 at 09:33
    • #

    Great piece!


Leave a comment

Please login to leave a comment.


Legal Advisors

Upcoming Events

There are no up-coming events

Copyright © LawInSport Limited 2010 - 2022. These pages contain general information only. Nothing in these pages constitutes legal advice. You should consult a suitably qualified lawyer on any specific legal problem or matter. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. LawInSport is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.